The slip
PARKINSON RECEIPTno. 14023
29 Oct 2026, 11:08 UTCdopamine neurons, braak
predictionTMEM184B in dopamine neurons tracks Braak Lewy-body stage
registered49f58f2b8d0c9a20
discovery-0.15 p=0.705 n=9
replication-0.66 p=0.053 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.15, p 0.705)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT11d75fbf745b8fbaca1a29f4…
follows a617bef866bf…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 14023: TMEM184B in dopamine neurons, braak
- power
- full sample -0.48 (p 0.046, n 18), 95% CI -0.77 to -0.01. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.48 (p 0.045, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.59 (p 0.0096, n 18). not the mix.
- skeptic
- leave-one-out range -0.65 to -0.41, sign flips 0; without severely affected donors -0.48 (p 0.046, n 18). robust.
- cell type
- strongest in OPCs: -0.61 (p 0.0069, n 18) vs -0.48 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for TMEM184B in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up TMEM184B · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.43 p 0.131 (needs p < 1.7e-4)